In addition, Pillinger et al. [30] revealed that PI3K inhibition using three PI3K inhibitors, LY294002, IPI-145, and CAL-101, significantly reduced the survival of AML cells in vitro or in vivo. The gene discussed is PIK3CA; the disease is acute myeloid leukemia.